Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 244.00M
March 31, 2026 -38.00M
December 31, 2025 46.00M
September 30, 2025 127.00M
June 30, 2025 180.00M
March 31, 2025 -69.00M
December 31, 2024 124.00M
September 30, 2024 112.00M
June 30, 2024 166.00M
March 31, 2024 -22.00M
December 31, 2023 116.00M
September 30, 2023 165.00M
June 30, 2023 19.00M
March 31, 2023 -183.00M
December 31, 2022 -66.00M
September 30, 2022 143.00M
June 30, 2022 279.00M
Date Value
March 31, 2022 -88.00M
December 31, 2021 132.00M
September 30, 2021 64.00M
June 30, 2021 124.00M
March 31, 2021 -34.00M
December 31, 2020 -239.80M
September 30, 2020 -199.90M
June 30, 2020 131.50M
March 31, 2020 -40.10M
December 31, 2019 14.90M
September 30, 2019 5.40M
June 30, 2019 28.80M
March 31, 2019 -22.40M
December 31, 2018 79.30M
September 30, 2018 146.10M
June 30, 2018 113.10M
March 31, 2018 14.30M

Free Cash Flow Definition

Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

View Free Cash Flow (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow (Quarterly) Benchmarks

View Free Cash Flow (Quarterly) Benchmarks
Start Trial
Zoetis, Inc. 538.00M
ANI Pharmaceuticals, Inc. 53.62M
Eli Lilly & Co. 4.475B
Corcept Therapeutics, Inc. 31.02M
Veru, Inc. -5.467M